Late effects in long-term survivors after treatment for childhood acute leukemia
- PMID: 19264722
- DOI: 10.1177/0009922809332680
Late effects in long-term survivors after treatment for childhood acute leukemia
Abstract
Background: This is a report of late effects in childhood cancer survivors seen in the follow-up clinic of a single institution.
Materials and methods: There were 324 acute leukemia survivors in the database of the Long Term Follow Up Clinic of Children's National Medical Center from January 1, 1997, through June 30, 2005.
Results: Of the 324 acute leukemia survivors, 228 were white, 48 black, 20 Hispanic, and 12 other. Their follow-up time was 0 to 25 years (mean 5.3 years). One or more adverse events occurred in 74.1% of the 324 survivors. Defective physical growth was most commonly reported, followed by disturbed neurocognitive function, emotional difficulties, cardiac abnormalities, hypertension, osteoporosis/osteopenia, fractures, and second neoplasms. More black and Hispanic children had acute myeloid leukemia, relapses, cardiac problems, and hypertension than white and other subjects.
Conclusion: Childhood cancer survivors require lifelong monitoring, with prompt identification and treatment of adverse late effects.
Similar articles
-
[Outcome of children cured of acute lymphoblastic leukemia].Bull Acad Natl Med. 2009 Oct;193(7):1519-28. Bull Acad Natl Med. 2009. PMID: 20669633 Review. French.
-
Second neoplasms in survivors of childhood and adolescent cancer are often treatable.J Adolesc Health. 2004 Apr;34(4):324-9. doi: 10.1016/j.jadohealth.2003.07.006. J Adolesc Health. 2004. PMID: 15041002
-
High health-related quality of life among long-term survivors of childhood acute lymphoblastic leukemia.Pediatr Blood Cancer. 2010 Aug;55(2):331-6. doi: 10.1002/pbc.22531. Pediatr Blood Cancer. 2010. PMID: 20582965
-
Late effects risk profiles using the long-term follow-up guidelines in identical twin survivors of acute lymphoblastic leukemia.Pediatr Blood Cancer. 2007 Sep;49(3):349-52. doi: 10.1002/pbc.20835. Pediatr Blood Cancer. 2007. PMID: 16602119
-
Obesity in pediatric oncology.Pediatr Blood Cancer. 2005 Dec;45(7):881-91. doi: 10.1002/pbc.20451. Pediatr Blood Cancer. 2005. PMID: 16035086 Review.
Cited by
-
Hepatic late adverse effects after antineoplastic treatment for childhood cancer.Cochrane Database Syst Rev. 2019 Apr 15;4(4):CD008205. doi: 10.1002/14651858.CD008205.pub3. Cochrane Database Syst Rev. 2019. PMID: 30985922 Free PMC article.
-
Investigation of the Relationship Between Fok1 and Col1A1 Gene Polymorphisms and Development of Treatment-Related Bone Complications in Children with Acute Lymphoblastic Leukemia.Turk J Haematol. 2019 Feb 7;36(1):12-18. doi: 10.4274/tjh.galenos.2018.2018.0221. Epub 2018 Sep 25. Turk J Haematol. 2019. PMID: 30251958 Free PMC article.
-
Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.Cancer Cell. 2018 Aug 13;34(2):271-285.e7. doi: 10.1016/j.ccell.2018.07.007. Cancer Cell. 2018. PMID: 30107177 Free PMC article.
-
Vitamin D insufficiency among children with cancer in India.Indian J Med Paediatr Oncol. 2016 Jan-Mar;37(1):14-9. doi: 10.4103/0971-5851.177009. Indian J Med Paediatr Oncol. 2016. PMID: 27051151 Free PMC article.
-
Children's Oncology Group's 2013 blueprint for research: survivorship and outcomes.Pediatr Blood Cancer. 2013 Jun;60(6):1063-8. doi: 10.1002/pbc.24422. Epub 2012 Dec 19. Pediatr Blood Cancer. 2013. PMID: 23255494 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources